LSX Biotech Startup CEO Forum

2021 session details

Agenda | Attendees | Hosts | Book

Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of US-based, pre-series A-funded, therapeutic Biotech companies.

Free to attend, pre-registration only, Chatham House Rule forum hosted on Zoom where all participants are active discussants. 

  • Benchmark yourself against your peers
  • Uncover key factors of success
  • Share war stories and common challenges
  • Engage in peer-to-peer discussion
  • Make meaningful connections
  • Find new ways to help your business thrive

Agenda (All times in EDT)

13:00 Welcome

Introduction from LSX to the forum, introductions from all participants and sharing of pre event benchmarking survey results

13:10 Key Insight Case Study With Q&A: How to Prevent a Bad Day for Your Start-Up: IP Lessons Learned from Company Formation, Drug Development, Partnering & Due Diligence

  • How company formation and structure can affect intellectual property (IP) rights
  • How to maintain confidentiality in early-stage deals
  • What to disclose and to whom
  • How to keep IP assets safe from disgruntled former employees

Chad Shear, Principal, Fish & Richardson

Chad Shear, Principal, Fish & Richardson

13:30 Executive Led Discussion: Securing Your Series A: What Investors Need to See (And What They Don't)

  • What level of pre-clinical or clinical data is needed?
  • Key milestones and the plan to reach them
  • The value in your valuation - clear IP, development and commercial strategy

Bibhash Mukhopadhyay, Experienced Independent Investor

Bibhash Mukhopadhyay, Experienced Independent Investor

13:40 Interactive discussion and Q&A

13:55 Key Insight Case Study With Q&A: Partnering to Address the Challenges of a Start Up

  • Understanding the challenges of a start-up with limited resources and experience
  • Overcoming start-up hurdles
  • Navigating the regulatory environment

Sameena Sharif, President, RPI, Premier Research
Nancy Koch, JD, CEO, Ophirex

Sameena Sharif, President, RPI, Premier Research    Nancy Koch, JD, CEO, Ophirex

14:15 General Discussion (suggested topics to include but not limited to)

  • Securing investment from the right investors in a crowded but booming market
  • Business resilience in your biotech startup from the outset
  • Planning your clinical and regulatory roadmap  
  • Building and maintaining networks early to leverage in the future
  • Developing and maintaining the right partnerships to grow your business

15:00 Close Biotech Start Up CEO Forum


    Enable Therapeutics    Escend Pharmaceuticals    Etta Biotechnology 300x  Guided Clarity   

    Kenjockety Biotechnology    OncoSpherix 300x    OsteoDx 300x  Pano Therapeutics   

    Perfusion Medical    Pyrefin    Sidereal Therapeutics  TRIO Pharmaceuticals    

    Valley Fever Solutions    Ophirex    Veana Therapeutics    SciBac    
    SemaThera    MIGRA-Therapeutics    Ibex Biosciences    Nanocell    
    Oxidien Pharmaceuticals    Nanovery    Phyteau    



    Fish & Richardson 300x    Premier Research 300x150